Academic Sponsor-Investigator View of the Value of the EFS Program - Patrick Kelly, MD

↳ This is a section part of Moment: CRT 2015 Technology & Innovation - Session I: Improving the US Clinical Studies Ecosystem: The Impact of Recent Initiatives and the Potential for Future Improvements

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$5.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Academic Sponsor-Investigator View of the Value of the EFS Program presented by Patrick Kelly, MD at CRT 2015

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$5.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists
  • Interventional Fellows
  • Physicians with an interest in Cardiovascular Innovations 

Session Name: Session I: Improving the US Clinical Studies Ecosystem: The Impact of Recent Initiatives and the Potential for Future Improvements

Track: Technology & Innovation

Learning Objectives

  • Updates in the latest Cardiovascular Innovations

Other Components in this Moment

Overview
FDA Early Feasibility Study (EFS) Program Update On How the Program Is Changing the Landscape - Andrew Farb, MD
Academic Sponsor-Investigator View of the Value of the EFS Program - Patrick Kelly, MD
Small VC-Backed Company View Regarding the Nonclinical Data Requirements for Justifying Clinical Study Initiation as Compared to Non-US Systems - Vicki L. Bebeau, RN
Large Manufacturer View on the Outstanding Challenges - Stanton Rowe
Loading Simple Education